BPC-157 (10mg Vial) Dosage Protocol

Quickstart Highlights

BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid peptide derived from a gastric protein fragment and studied for tissue-repair and cytoprotective effects. Preclinical models show accelerated wound healing and anti-inflammatory activity, while human clinical evidence remains limited to early-phase safety studies and small case reports. This educational protocol outlines a once-daily subcutaneous approach using a practical dilution to allow clear insulin-syringe measurements.

Reconstitute: Add 3.0 mL bacteriostatic water → 3.33 mg/mL concentration.
Typical daily range: 200–600 mcg once daily (gradual titration).
Easy measuring: At 3.33 mg/mL, 1 unit = 0.01 mL ≈ 33.3 mcg on a U-100 insulin syringe.
Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.

Dosing & Reconstitution Guide

Educational guide for reconstitution and daily dosing

Standard / Gradual Approach (3 mL = ~ 3.33 mg/mL)

WEEK	Daily Dose (MCG)	UNITS (PER INJECTION) (ML)
Weeks 1–2	200 mcg (0.2 mg)	6 units (0.06 mL)
Weeks 3–4	400 mcg (0.4 mg)	12 units (0.12 mL)
Weeks 5–8+	600 mcg (0.6 mg)	18 units (0.18 mL)

Frequency: Inject once daily subcutaneously. This schedule uses the largest practical dilution (3.0 mL) to keep per-injection units well above 5 for better accuracy. Dosing is extrapolated from preclinical models; human clinical validation remains limited..

Reconstitution Steps

Draw 3.0 mL bacteriostatic water with a sterile syringe.
Inject slowly down the vial wall; avoid foaming.
Gently swirl/roll until dissolved (do not shake).
Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Supplies Needed

Plan based on an 8–16 week daily protocol with gradual titration.

Peptide Vials (BPC-157, 10 mg each):
- 8 weeks ≈ 3 vials (25.2 mg used)
- 12 weeks ≈ 5 vials (42 mg used)
- 16 weeks ≈ 6 vials (58.8 mg used)
Insulin Syringes (U-100):
- Per week: 7 syringes (1/day)
- 8 weeks: 56 syringes
- 12 weeks: 84 syringes
- 16 weeks: 112 syringes
Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.
- 8 weeks (3 vials): 9 mL → 1 × 10 mL bottle
- 12 weeks (5 vials): 15 mL → 2 × 10 mL bottles
- 16 weeks (6 vials): 18 mL → 2 × 10 mL bottles
Alcohol Swabs: One for the vial stopper + one for the injection site each day.
- Per week: 14 swabs (2/day)
- 8 weeks: 112 swabs → recommend 2 × 100-count boxes
- 12 weeks: 168 swabs → recommend 2 × 100-count boxes
- 16 weeks: 224 swabs → recommend 3 × 100-count boxes

Protocol Overview

Concise summary of the once-daily regimen.

Goal: Support tissue-healing and recovery processes based on preclinical evidence.
Schedule: Daily subcutaneous injections for 8–12 weeks (extend to 16 weeks if desired).
Dose Range: 200–600 mcg per day with gradual titration.
Reconstitution: 3.0 mL per 10 mg vial (~3.33 mg/mL) to enable accurate unit-based measurements.
Storage: Lyophilized stored frozen; after reconstitution, refrigerate and avoid repeated freeze–thaw cycles.

Dosing Protocol

Suggested daily titration approach.

- Start: 200 mcg daily; increase by ~200 mcg every 2 weeks as tolerated.
- Target: 400–600 mcg daily by Weeks 5–8+.
- Frequency: Once per day (subcutaneous).
- Cycle Length: 8–12 weeks; optional extension to 16 weeks.
- Timing: Any consistent time; rotate injection sites.

Storage Instructions

Proper storage preserves peptide quality.

Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; minimize moisture exposure.
Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); prepare aliquots if needed and avoid freeze–thaw.
Allow vials to reach room temperature before opening to reduce condensation uptake.

Important Notes

Practical considerations for consistency and safety.

Use new sterile insulin syringes for each injection; dispose in a sharps container.
Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation.
Inject slowly; wait a few seconds before withdrawing the needle.
Document daily dose and site rotation to maintain consistency.
BPC-157 human data are preliminary; clinical decisions should involve qualified healthcare providers.

How it works

BPC-157 is a synthetic peptide that corresponds to a partial sequence of a human gastric juice protein. Preclinical research indicates it influences nitric oxide signaling and growth-factor expression, supporting angiogenesis and collagen formation in injured tissues. Animal studies describe accelerated repair of the gut, tendons, ligaments, and muscle. A Phase I oral safety study has been completed, and a small human case series noted improvements after intra-articular administration; however, large, controlled human efficacy trials are still lacking.

Potential Benefits & Side Effects

Observations from preclinical and early clinical literature.

Supports tissue repair across gut, tendon, muscle, and skin injury models (animal data).
Exhibits anti-inflammatory and cytoprotective effects in preclinical contexts.
Phase I safety studies indicate good tolerability with no serious adverse events at evaluated doses.
Occasional mild injection-site reactions (redness, itching) may occur with subcutaneous use.
Long-term human safety and efficacy continue to be under investigation.

Lifestyle Factors

Complementary strategies for best outcomes.

Support recovery with sufficient protein intake and micronutrient-dense foods.
Balance physical activity with adequate rest to allow tissue adaptation without overuse.
Prioritize quality sleep and effective stress management to support natural healing processes.
Consult qualified healthcare professionals for injury-specific rehabilitation guidance.

Injection Technique

General subcutaneous guidance from clinical best-practice resources.

Clean the vial stopper and skin with alcohol; allow to dry.
Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue.
Do not aspirate for subcutaneous injections; inject slowly and steadily.
Rotate sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy.
Discard used syringes immediately in a sharps container per WHO guidelines.

Recommended Source

We recommend Ion Peptide for high-purity BPC-157 (10 mg).

Why Ion Peptide?

High-purity, third-party-tested lots with batch COAs.
Consistent, ISO-aligned handling and documentation.
Reliable fulfillment to maintain cold-chain integrity.

Shop at Ion Peptides

Important Note

This content is for educational purposes only and is not medical advice, diagnosis, or treatment. BPC-157 remains investigational with limited human clinical data. For research use only. Not for human consumption.